Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

China flag China · Delayed Price · Currency is CNY
53.82
-1.55 (-2.80%)
Sep 6, 2024, 3:00 PM CST
68.29%
Market Cap 21.89B
Revenue (ttm) 2.39B
Net Income (ttm) 657.61M
Shares Out 406.80M
EPS (ttm) 1.62
PE Ratio 33.24
Forward PE 24.42
Dividend 0.41 (0.76%)
Ex-Dividend Date May 23, 2024
Volume 1,330,866
Open 55.87
Previous Close 55.37
Day's Range 53.73 - 55.87
52-Week Range 31.06 - 69.97
Beta 0.35
Analysts n/a
Price Target n/a
Earnings Date Oct 24, 2024

About Xiamen Amoytop Biotech

Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 1,960
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688278
Full Company Profile

Financial Performance

In 2023, 688278's revenue was 2.10 billion, an increase of 37.55% compared to the previous year's 1.53 billion. Earnings were 555.45 million, an increase of 93.52%.

Financial Statements

News

There is no news available yet.